European Hematology Association
Europe's haematology society, whose June congress is the second global venue for blood cancer trials and whose guidelines and curriculum shape European haematology.
Founded in 1992, EHA represents haematologists across Europe and beyond, with its annual congress each June attracting more than 15,000 delegates and presenting major leukaemia, lymphoma and myeloma data alongside ASH. It publishes HemaSphere, issues clinical guidelines and the European Hematology Curriculum, runs research fellowships and the EHA-ASH Translational Research Training in Hematology programme, and advocates in Brussels on medicines regulation, rare diseases and research funding. Its Scientific Working Groups on CLL, myeloma, AML, MDS and lymphoma link the national cooperative groups such as HOVON, GIMEMA and the German study groups.
- EHA Congress (June)
- HemaSphere
- Clinical guidelines and European Hematology Curriculum
- Fellowships and EHA-ASH training
Leads the German CLL Study Group, whose trials (CLL8, CLL14, CLL13) set global standards for CLL treatment.
Lars Bullinger is a haematologist and AML genomics researcher leading Charité's haematology department.
Pages like this
not linked directly; found by shared links- CollectionLeukemia & Lymphoma Society (LLS)
Shares American Society of Hematology, Hodgkin lymphoma, Chronic lymphocytic leukaemia, Multiple myeloma.
- InstitutionIRCCS Azienda Ospedaliero-Universitaria di Bologna – Policlinico Sant'Orsola
Shares Bispecific antibodies, Hodgkin lymphoma, Multiple myeloma, Acute myeloid leukaemia.
- IdeaPlan the second CAR-T target before the first one is lost
Shares Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma, Acute lymphoblastic leukaemia.
- TechnologyMultiparameter flow cytometry MRD
Shares Minimal / molecular residual disease (MRD), Chronic lymphocytic leukaemia, MRD / molecular residual disease testing, Multiple myeloma.
- InstitutionIUCT Oncopole – Institut Universitaire du Cancer de Toulouse
Shares Bispecific antibodies, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma.
- InstitutionNordic Lymphoma Group
Shares HOVON, Hodgkin lymphoma, Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma.
- InstitutionSeoul St. Mary's Hospital
Shares Multiple myeloma, Acute lymphoblastic leukaemia, Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- TermFlow cytometry (immunophenotyping)
Shares Minimal / molecular residual disease (MRD), Chronic lymphocytic leukaemia, Multiple myeloma, Acute lymphoblastic leukaemia.